Hans Van Hulle
Overview
Explore the profile of Hans Van Hulle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vakaet V, Van Hulle H, De Noyette R, Schoepen M, Deseyne P, Huybrechts V, et al.
Br J Radiol
. 2024 Nov;
98(1165):45-49.
PMID: 39531272
Objectives: Deep inspiration breath-holds (DIBHs) reduce heart and lung toxicity during breast cancer radiotherapy. Consecutive DIBHs are stressful, time-consuming, and leads to position changes. To facilitate the introduction of pre-oxygenation...
2.
Naert E, Van Hulle H, De Jaeghere E, Orije M, Roels S, Salihi R, et al.
Qual Life Res
. 2024 Feb;
33(5):1401-1414.
PMID: 38396183
Purpose: To assess experiences of sexuality and of receiving sexual healthcare in cervical cancer (CC) survivors. Methods: A qualitative phenomenological study using semistructured one-on-one interviews was conducted with 15 Belgian...
3.
Vakaet V, Deseyne P, Bultijnck R, Post G, West C, Azria D, et al.
Acta Oncol
. 2023 Aug;
62(9):1036-1044.
PMID: 37548182
Objective: Most patients receive whole breast radiotherapy in a supine position. However, two randomised trials showed lower acute toxicity in prone position. Furthermore, in most patients, prone positioning reduced doses...
4.
Vakaet V, Deseyne P, Schoepen M, Stouthandel M, Post G, Speleers B, et al.
Pract Radiat Oncol
. 2022 Jun;
12(4):324-334.
PMID: 35717049
Purpose: Prone whole breast irradiation results in lower dose to organs at risk compared with supine position, especially lung dose. However, the adoption of prone position for whole breast irradiation ...
5.
Aldraimli M, Osman S, Grishchuck D, Ingram S, Lyon R, Mistry A, et al.
Adv Radiat Oncol
. 2022 Jun;
7(3):100890.
PMID: 35647396
Purpose: Some patients with breast cancer treated by surgery and radiation therapy experience clinically significant toxicity, which may adversely affect cosmesis and quality of life. There is a paucity of...
6.
Vakaet V, Van Hulle H, Quataert V, Deseyne P, Schoepen M, Paelinck L, et al.
Breast Dis
. 2022 May;
41(1):261-266.
PMID: 35599462
Introduction: Postmastectomy radiotherapy reduces the risk of locoregional recurrence in breast cancer patients. The first results on accelerated radiotherapy in five fractions after breast conserving surgery are promising. The data...
7.
Deseyne P, Speleers B, Paelinck L, De Gersem W, De Neve W, Schoepen M, et al.
Sci Rep
. 2022 Feb;
12(1):1887.
PMID: 35115610
In whole breast and regional nodal irradiation (WB + RNI), breathhold increases organ at risk (OAR) sparing. WB + RNI is usually performed in supine position, because positioning materials obstruct...
8.
Vakaet V, Van Hulle H, Van de Vijver K, Hilderson I, Naert E, De Neve W, et al.
Breast
. 2022 Jan;
62:10-15.
PMID: 35091184
Objective: Neo-adjuvant radiotherapy (NART) for breast cancer has shown promising survival results in retrospective trials. However, there are some obstacles such as a chemotherapy delay, an increased overall treatment time...
9.
Vakaet V, Van Hulle H, Schoepen M, Van Caelenberg E, Van Greveling A, Holvoet J, et al.
Clin Transl Radiat Oncol
. 2021 Mar;
28:10-16.
PMID: 33732910
Background And Purpose: Deep inspiration breath-hold is an established technique to reduce heart dose during breast cancer radiotherapy. However, modern breast cancer radiotherapy techniques with lymph node irradiation often require...
10.
Van Hulle H, Desaunois E, Vakaet V, Paelinck L, Schoepen M, Post G, et al.
Radiother Oncol
. 2021 Feb;
158:62-66.
PMID: 33617910
Introduction: A simultaneous integrated boost (SIB) leads to less acute toxicity. Less is known for late toxicity due to SIB. In this first and only randomized trial, two-years toxicity is...